GlaxoSmithKline: Pneumonia trials

The registry lists 13 Pneumonia studies with GlaxoSmithKline as lead sponsor. 0 are open to participants now and 6 have results posted.

Phase 1 1Phase 2 3Phase 3 6No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy InfantsCompletedNCT05412030Phase 2Results posted
• A Study to Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy InfantsCompletedNCT02447432Phase 3Results posted
• Prophylactic Efficacy of Relenza Against Influenza A and BCompletedNCT01156701Results posted
• Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive DiseaseCompletedNCT00861380Phase 3Results posted
• COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate VaccineCompletedNCT00466947Phase 3Results posted
• Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine.CompletedNCT00370396Phase 3Results posted
• Vaccination Impact Against Pneumococcal Disease on Acute Otitis Media Morbidity in Colombian Children < 5 Years of AgeCompletedNCT02567747
• Exploratory Study in Healthy Elderly Subjects to Collect Urine for Development of Assays to Detect S. PneumoniaeCompletedNCT00523770
• Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate VaccineCompletedNCT00370227Phase 3
• Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine.CompletedNCT00334334Phase 3
• Study to Evaluate the Safety and Immunogenicity of an Investigational Pneumococcal Vaccine in the Elderly PopulationCompletedNCT00327665Phase 1
• Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly PopulationCompletedNCT00307528Phase 2
• Study to Evaluate the Response Rate to the Licensed Pneumovax 23™ in Elderly Population.CompletedNCT00307008Phase 2